Boston University
A pax of all trades: discovering a novel role for the transcription factor paired box 3 as a promoter of nonsense mediated decay
Abstract
dc:description.abstractThe main canonical function of Paired Box 3 (PAX3) is to act as a transcription factor, where it drives development in the neural crest and neural-crest derived tissues. PAX3 is downregulated as development continues but is frequently upregulated in melanoma. In the context of melanoma, PAX3 has been assumed to drive cancer progression by transcriptionally activating genes that improve tumor survivability and invasion. However, this known role may not fully explain the wide impact of PAX3 on melanoma progression (growth, survival, migration, inhibition of differentiation) and may be due to other, non-characterized roles. We discovered PAX3 interaction with RNA-processing proteins, most notably exon junction complex (EJC) and RNA degradation proteins, indicating a possible connection to nonsense-mediated decay (NMD). NMD is an RNA quality-control and regulation pathway that degrades mRNAs containing premature termination codons. PAX3 overexpression was shown to increase NMD activity by multiple metrics. This includes a reduction in RNA of known NMD-targeted transcripts and reduction in signal in an NMD-targeted reporter system, indicating that PAX3 was improving degradation of transcripts that are vulnerable to NMD-targeting. Further, PAX3 overexpression also increased UPF1 phosphorylation, an early marker of NMD activation, indicating that PAX3 is a positive regulator of NMD. PAX3-NMD was not reliant on RNA binding, splicing alterations, or transcriptional activity, supporting that PAX3-mediated NMD is driven through protein-protein interactions. PAX3-NMD functions to suppress apoptotic and tumor-suppressor pathways that drive melanoma survival and growth, as supported by transcriptome analysis. Deletion and mutation of the PAX3 protein established that PAX3-NMD activity is not dependent on PAX3’s transcriptional domains or previously described regulatory regions. Instead, PAX3-NMD activity appears to be dependent on a previously uncharacterized polar region that may be a site for protein-protein interactions. Deletion of the polar region removes PAX3’s ability to drive NMD without affecting transcriptional activity. Here, we find a novel and transcriptionally independent function of PAX3 in promoting melanoma progression by acting through the NMD pathway. The main canonical function of Paired Box 3 (PAX3) is to act as a transcription factor, where it drives development in the neural crest and neural-crest derived tissues. PAX3 is downregulated as development continues but is frequently upregulated in melanoma. In the context of melanoma, PAX3 has been assumed to drive cancer progression by transcriptionally activating genes that improve tumor survivability and invasion. However, this known role may not fully explain the wide impact of PAX3 on melanoma progression (growth, survival, migration, inhibition of differentiation) and may be due to other, non-characterized roles. We discovered PAX3 interaction with RNA-processing proteins, most notably exon junction complex (EJC) and RNA degradation proteins, indicating a possible connection to nonsense-mediated decay (NMD). NMD is an RNA quality-control and regulation pathway that degrades mRNAs containing premature termination codons. PAX3 overexpression was shown to increase NMD activity by multiple metrics. This includes a reduction in RNA of known NMD-targeted transcripts and reduction in signal in an NMD-targeted reporter system, indicating that PAX3 was improving degradation of transcripts that are vulnerable to NMD-targeting. Further, PAX3 overexpression also increased UPF1 phosphorylation, an early marker of NMD activation, indicating that PAX3 is a positive regulator of NMD. PAX3-NMD was not reliant on RNA binding, splicing alterations, or transcriptional activity, supporting that PAX3-mediated NMD is driven through protein-protein interactions. PAX3-NMD functions to suppress apoptotic and tumor-suppressor pathways that drive melanoma survival and growth, as supported by transcriptome analysis. Deletion and mutation of the PAX3 protein established that PAX3-NMD activity is not dependent on PAX3’s transcriptional domains or previously described regulatory regions. Instead, PAX3-NMD activity appears to be dependent on a previously uncharacterized polar region that may be a site for protein-protein interactions. Deletion of the polar region removes PAX3’s ability to drive NMD without affecting transcriptional activity. Here, we find a novel and transcriptionally independent function of PAX3 in promoting melanoma progression by acting through the NMD pathway.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Molecular and Translational Medicine
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Prince, Noah Barnes
- Advisor dc:contributor.advisor
-
- Lang, Deborah
Subjects
dc:subject × 8Rights
dc:rights- Statement dc:rights
-
- Attribution 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53463